Gregory Reardon

1.1k total citations
42 papers, 847 citations indexed

About

Gregory Reardon is a scholar working on Epidemiology, Ophthalmology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Gregory Reardon has authored 42 papers receiving a total of 847 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 12 papers in Ophthalmology and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Gregory Reardon's work include Glaucoma and retinal disorders (11 papers), Retinal Diseases and Treatments (8 papers) and Atrial Fibrillation Management and Outcomes (6 papers). Gregory Reardon is often cited by papers focused on Glaucoma and retinal disorders (11 papers), Retinal Diseases and Treatments (8 papers) and Atrial Fibrillation Management and Outcomes (6 papers). Gregory Reardon collaborates with scholars based in United States, Canada and United Kingdom. Gregory Reardon's co-authors include Gail F. Schwartz, Essy Mozaffari, Winnie W. Nelson, Aarti A. Patel, Robert W. Platt, Eric J. Drinkwater, David G. Behm, James A. Fitzgerald, G SCHWARTZ and Brahim Bookhart and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Ophthalmology and American Journal of Ophthalmology.

In The Last Decade

Gregory Reardon

40 papers receiving 814 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gregory Reardon United States 17 510 195 167 115 76 42 847
A F Spencer United Kingdom 15 508 1.0× 73 0.4× 311 1.9× 41 0.4× 65 0.9× 35 781
E Shyong Tai Singapore 17 412 0.8× 84 0.4× 380 2.3× 130 1.1× 57 0.8× 33 1.1k
Yohalakshmi Chelladurai United States 14 211 0.4× 94 0.5× 120 0.7× 102 0.9× 131 1.7× 24 1.2k
Paul Benitez‐Aguirre Australia 18 364 0.7× 35 0.2× 337 2.0× 156 1.4× 179 2.4× 47 983
M. Airey United Kingdom 8 285 0.6× 40 0.2× 242 1.4× 20 0.2× 70 0.9× 14 579
Steven Kelly United Kingdom 9 72 0.1× 61 0.3× 39 0.2× 116 1.0× 230 3.0× 12 564
E. T. Lee United States 11 83 0.2× 53 0.3× 70 0.4× 120 1.0× 153 2.0× 14 663
Lionel S. Lim United States 13 104 0.2× 65 0.3× 94 0.6× 82 0.7× 131 1.7× 24 727
Paola Valsania United States 10 49 0.1× 53 0.3× 60 0.4× 110 1.0× 113 1.5× 11 499
Javid Sadjadi United States 19 44 0.1× 53 0.3× 52 0.3× 147 1.3× 334 4.4× 39 828

Countries citing papers authored by Gregory Reardon

Since Specialization
Citations

This map shows the geographic impact of Gregory Reardon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Reardon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Reardon more than expected).

Fields of papers citing papers by Gregory Reardon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory Reardon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Reardon. The network helps show where Gregory Reardon may publish in the future.

Co-authorship network of co-authors of Gregory Reardon

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory Reardon. A scholar is included among the top collaborators of Gregory Reardon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory Reardon. Gregory Reardon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ajani, Jaffer A., Lai K. Leung, Steve Kanters, et al.. (2024). Disease-free survival as surrogate for overall survival in real-world settings for esophageal cancer: an analysis of SEER-Medicare data. ESMO Open. 9(11). 103934–103934. 2 indexed citations
2.
3.
Reardon, Gregory, Evan T. Robinson, Sheldon M. Schuster, & Gayle A. Brazeau. (2023). Advancing Systems Citizenship in Colleges and Schools of Pharmacy. American Journal of Pharmaceutical Education. 87(5). 100008–100008. 3 indexed citations
4.
Patel, Aarti A., et al.. (2013). Persistence of Warfarin Therapy for Residents in Long-term Care Who Have Atrial Fibrillation. Clinical Therapeutics. 35(11). 1794–1804. 12 indexed citations
5.
Reardon, Gregory, Naushira Pandya, Edith A. Nutescu, et al.. (2013). Incidence of Venous Thromboembolism in Nursing Home Residents. Journal of the American Medical Directors Association. 14(8). 578–584. 18 indexed citations
6.
7.
Reardon, Gregory, et al.. (2012). Falls in nursing home residents receiving pharmacotherapy for anemia. Clinical Interventions in Aging. 7. 397–397. 6 indexed citations
8.
Reardon, Gregory, et al.. (2012). Usage of medications with high potential to interact with warfarin among atrial fibrillation residents in long-term care facilities. Expert Opinion on Pharmacotherapy. 14(2). 165–173. 2 indexed citations
9.
Reardon, Gregory, Naushira Pandya, Edith A. Nutescu, et al.. (2012). Use of Warfarin Therapy Among Residents Who Developed Venous Thromboembolism in the Nursing Home. ˜The œAmerican journal of geriatric pharmacotherapy. 10(6). 361–372. 10 indexed citations
10.
Bailey, Robert A., et al.. (2012). Association of anemia with worsened activities of daily living and health-related quality of life scores derived from the Minimum Data Set in long-term care residents. Health and Quality of Life Outcomes. 10(1). 129–129. 22 indexed citations
11.
12.
13.
Schwartz, Gail F., Robert W. Platt, Gregory Reardon, & Marko A. Mychaskiw. (2007). Accounting for Restart Rates in Evaluating Persistence with Ocular Hypotensives. Ophthalmology. 114(4). 648–652. 36 indexed citations
14.
Bhosle, Monali, Gregory Reardon, Fabian Camacho, Roger T. Anderson, & Rajesh Balkrishnan. (2007). Medication adherence and health care costs with the introduction of latanoprost therapy for glaucoma in a medicare managed care population. ˜The œAmerican journal of geriatric pharmacotherapy. 5(2). 100–111. 20 indexed citations
15.
Reardon, Gregory, et al.. (2005). Cost–Effectiveness of Ocular Prostaglandins in the First Year Using Persistency on Therapy to Define Treatment Success. Investigative Ophthalmology & Visual Science. 46(13). 1961–1961. 1 indexed citations
16.
Reardon, Gregory, et al.. (2004). Association between Ocular Herpes Simplex Virus and Topical Ocular Hypotensive Therapy. Journal of Glaucoma. 13(5). 361–364. 14 indexed citations
17.
SCHWARTZ, G & Gregory Reardon. (2004). A Cost-effectiveness Comparison of Bimatoprost versus Latanoprost in Patients with Glaucoma or Ocular Hypertension. Survey of Ophthalmology. 49(2). 621–623. 20 indexed citations
18.
Schwartz, Gail F., Gregory Reardon, & Essy Mozaffari. (2003). Persistency with latanoprost or timolol in primary open-angle glaucoma suspects. American Journal of Ophthalmology. 137(1). S13–S16. 76 indexed citations
19.
Platt, Robert W., Gregory Reardon, & Essy Mozaffari. (2003). Observed time between prescription refills for newer ocular hypotensive agents: the effect of bottle size. American Journal of Ophthalmology. 137(1). S17–S23. 21 indexed citations
20.
Reardon, Gregory, Gail F. Schwartz, & Essy Mozaffari. (2003). Patient Persistency with ocular prostaglandin therapy: A population-based, retrospective study. Clinical Therapeutics. 25(4). 1172–1185. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A F Spencer Breakdown of academic impact, for papers by E Shyong Tai Breakdown of academic impact, for papers by Yohalakshmi Chelladurai Breakdown of academic impact, for papers by Paul Benitez‐Aguirre Breakdown of academic impact, for papers by M. Airey Breakdown of academic impact, for papers by Steven Kelly Breakdown of academic impact, for papers by E. T. Lee Breakdown of academic impact, for papers by Lionel S. Lim Breakdown of academic impact, for papers by Paola Valsania Breakdown of academic impact, for papers by Javid Sadjadi
Rankless by CCL
2026